ChromaDex Corporation

(CDXC) Trade

By |

Profile

ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world AGE BETTER. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.

Contact Information

Website: www.chromadex.com
Email: InvestorRelations@chromadex.com
Main Phone: +949.419.0288 ext. 127
Address: 10900 Wilshire Boulevard
Address 2: Suite 650
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 90024

Issuer Information

Exchange: NSC
CEO: Robert N. Fried
Employees: 110
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

Profile

ChromaDex Corp. is a science-based integrated nutraceutical company devoted to improving the way people age. ChromaDex scientists partner with leading universities and research institutions worldwide to discover, develop and create solutions to deliver the full potential of NAD and its impact on human health. Its flagship ingredient, NIAGEN nicotinamide riboside, sold directly to consumers as TRU NIAGEN, is backed with clinical and scientific research, as well as extensive IP protection. TRU NIAGEN is helping the world AGE BETTER. ChromaDex maintains a website at www.chromadex.com to which ChromaDex regularly posts copies of its press releases as well as additional and financial information about the Company.

Contact Information

Website: www.chromadex.com
Email: InvestorRelations@chromadex.com
Main Phone: +949.419.0288 ext. 127
Address: 10900 Wilshire Boulevard
Address 2: Suite 650
State: CA
City / Town: Los Angeles
Country: US
Postal Code: 90024

Issuer Information

Exchange: NSC
CEO: Robert N. Fried
Employees: 110
NAICS: Medicinal and Botanical Manufacturing(325411)

Equities News

$ 5.01 $ 0.15 (3.09%)
Last Price 5.01 Change $ 0.15 Change % 3.09 Tick N/A
Bid 4.95 Bid Size 4,200.00 Ask 4.96 Ask Size 1,300.00
Open 4.86 High 5.07 Low 4.86 Prev Close 4.86
Last Trade Volume 167,688 52 Wk Hi 6.00 52 Wk Low 2.50
Market Cap 309.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 61,787,728.00 EPS (TTM) -0.38 PE Ratio -12.80 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 10 19
Number of Buys 8 14
Number of Sells 2 5
Net Activity 37800 383133
Last 10 Buys Shares
Kevin M. Farr 1,000
Mark J. Friedman 1,000
Frank L. Jaksch 1,000
Robert N. Fried 1,000
Frank L. Jaksch 1,000
Stephen Allen 1,000
Robert N. Fried 1,000
Stephen Allen 1,000
Stephen Allen 1,000
Frank L. Jaksch 1,000
Last 10 Sell Shares
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
Frank L. Jaksch 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 10.5 10.5 10.5 10.5
Low Target Price Estimate 8 8 8 8
Mean Target Price Estimate 9.25 9.25 9.25 9.25
Standard Deviation 1.77 1.77 1.77 1.77
Date of Most Recent Estimate 05/24/18 05/24/18 03/11/18 05/24/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1